Hope in the drug was revived on Wednesday when the US government’s top infectious disease expert, Dr Anthony Fauci said data from one clinical trial “shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery”. But within hours of Fauci’s announcement, the prestigious medical journal The Lancet published results from a study in China which found remdesivir did not speed recovery or reduce deaths from Covid-19 compared with a placebo in hospital patients.
So what should the public make of the seemingly conflicting remdisivir results? - For the FDA to approve a med not yet fully vetted is unusual, to say the least and what should the public make of the "seemingly conflicting remdisivir results"? - Someone is running for re-election and politics is alive and well, even though coronavirus victims are not.
Market Data 
Markets 
AI
